InVivo Therapeutics Corporation (NVIV) Appoints Steven McAllister As CFO

InVivo Therapeutics Corporation (NVIV) Appoints Steven McAllister As CFO

InVivo Therapeutics Holdings Corp. (NVIV) today announced the appointment of Steven McAllister as Chief Financial Officer, effective immediately. Mr. McAllister has been serving as InVivo's Interim CFO since December of 2013.

Mr. McAllister previously served as Vice President, Finance and Administration for Biomet Spine and Bone Healing Technologies (a private equity-owned medical device company) from 2007–2013, where he was responsible for all accounting, finance, IT, facilities, and insurance operations activities in addition to leading the company's strategic planning initiatives. 

Suggested Articles

Akero's FGF21 analog beat placebo at reducing liver fat in patients with nonalcoholic steatohepatitis (NASH).

Amgen has become the latest biopharma to try to figure out the hit it may take to its pipeline timings amid the COVID-19 pandemic.

The database was locked at the end of February but will only be unblinded after the FDA has provided feedback.